Your Global Analytical Services Partner

About Us

We support the domestic and global pharmaceutical industry from developmental stage to commercial products

Daicel Pharma Services has qualified and experienced scientists with vast industry knowledge and state-of-the-art instrumentation to develop and validate methods as per the requirements of regulatory agencies.

We offer a flexible approach which enables customers to choose from a wide selection of services to develop a project plan which meets their specific needs. Our team also adapts communication and reporting channels through a project management system to match customer specific requirements.

We have a team of scientists who are committed to providing the best services which meet the needs of pharmaceutical companies.


We currently offer a variety of expert services including:
  • Analytical Method Development, Validation including Method Transfers
  • Stability studies/analysis of samples
  • Analytical testing of high potent compounds
  • Reverse engineering (Excipient quantification in innovator vs developmental formulations)
All conducted in a GMP, US-FDA audited facility.

Spring 2019

We are excited to announce the opening of our new 50,000 square foot facility, in Spring 2019, allowing us to expand our services to include:
  • Extractables and Leachable studies
  • Batch Release testing
  • Stability studies and stress studies on drug substances and drug products
  • Microbiological analysis of pharmaceutical products (early 2020)
  • Biologics analytics (early 2020)

We are continually evolving to meet the changing world

Architect’s rendering of the new Daicel Chiral Technologies India facility

Our Senior Management

Dr. Ch.Lakshmi Narayana

Managing Director

Dr. Ch. Lakshmi Narayana, Founder and Managing Director at Daicel Chiral Technologies (India) Private Limited, has been instrumental in establishing the current direction and continuing growth at DCTI. Under his leadership, DCTI has become the preferred partner for several pharmaceutical companies in India and abroad.

Lakshmi holds a doctoral degree in Analytical Chemistry and delivered numerous lectures on chiral chromatography in national and international symposia. He has several research publications to his credit. Prior to joining Daicel Group in December 2006, he had successful stints in Dr. Reddy’s Laboratories Ltd., and GVK Biosciences.

MK Srinivasu-Ph.D

Head – Delivery Management

Dr. MK Srinivasu, Head – Delivery Management at Daicel Chiral Technologies (India) Private Limited, oversees the operations of Analytical Services, Separation Services, Project Management and Quality Assurance. Srinivasu is a vibrant industry leader with over 23 years of diversified analytical experience in the pharmaceutical industry and has worked with prestigious organizations such as Dr. Reddy’s Laboratories, Nektar Therapeutics and Daicel. He has valuable hands-on experience of establishing “GLP and GMP compliant” analytical development laboratories to enable IND, DMF and ANDA filings, as well as working with customers across the globe (US, Europe, Japan and ROW markets). His key skills include phase appropriate analytical method development of Clinical Phase Molecules (Custom Synthesis and Contract Manufacturing), DMF Filing of APIs, ANDA filing of formulation products, Animal Toxicology, Advanced Intermediates and Medicinal Chemistry. He is a principal author for more than 25 research papers being published both in Indian and international journals.